US-based biotechnology company Inceptor Bio has dosed the first subject in the investigator-initiated trial of its lead ...

Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today announced that the first patient has been dosed in the clinical trial of IB-T101, the company's ...

"It feels more like a coolly researched biography than one written by a passionate fan." What's more, Will Hermes tries to repackage the "violently aggressive, drug-huffing", gender-bending ...